24th Jun 2008 07:02
Consort Medical plc
Appointment of new Finance Director
Consort Medical plc, a leader in devices for inhaled drug delivery and anaesthesia, today announces the appointment of Toby Woolrych as Group Finance Director. Toby, aged 41, replaces Jon Glenn, who was appointed Chief Executive Officer on 5 December 2007. Paul Boughton the Company's Corporate Development Director has been acting Group Finance Director since that date.
Toby is joining Consort Medical in the autumn from ACTA SpA, an AIM listed Italian catalyst business where he was initially Chief Financial Officer and then Chief Operating Officer. Prior to that Toby was at Johnson Matthey plc, the FTSE100 specialty chemical company where he was Division Finance Director, Colours & Coatings Division and Managing Director Specialty Coatings. He qualified as an accountant at Arthur Andersen and is a member of the Institute of Chartered Accountants of England and Wales.
He has experience in the pharmaceutical markets both at Johnson Matthey and previously at Medicom International Ltd.
John Robinson, Consort Medical plc Chairman, said:
"We are very pleased that Toby has agreed to join the Company as Group Finance Director to work alongside Jon Glenn. Consort Medical has ambitious growth plans and some first class products in terms of valves that are in demand from pharmaceutical companies and patients alike to ensure the effective delivery of medicines to help people breathe.
"I would also like to thank Paul, on behalf of the Board and our shareholders, for acting as Chief Financial Officer over the last six months. "
Toby Woolrych has advised that, in accordance with paragraph 9.6.13 (2) - (6) of the Listing Rules, he has no details to disclose.
For further information, please contact:
|
Consort Medical plc |
|
|
John Robinson/Jon Glenn |
Tel: +44 (0) 1908 525240 |
|
Liz Morley/Brian Hudspith |
Tel: +44 (0) 20 7379 5151 |
About Consort Medical plc
Consort Medical plc is a leader in medical devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.
Consort Medical develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Milton Keynes in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).
Related Shares:
CSRT.L